AKTX ▲ +9.3% - Akari Therapeutics, Plc
$AKTX - Akari Therapeutics CEO Highlights Differentiated ADC Payload Strategy and Path Toward Clinical Development in New CEO Corner
15-OCT-2026 09:20 AM ET
Share this post
More filings for $AKTX
AKTX ▼ -0.1% - Akari Therapeutics, PlcOct 13, 2026AKTX ▲ +0.8% - Akari Therapeutics, PlcOct 1, 2026AKTX ▲ +3.3% - Akari Therapeutics, PlcAug 27, 2026AKTX - Akari Therapeutics, Plc - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 12, 2026AKTX - Akari Therapeutics, Plc - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026#AKTX-SEC-Update-(08-JUN-2026)-ThinkSabio-Stocks Simplified)Jun 9, 2026
View full $AKTX filing history →💬 Comments
Loading comments…
Leave a comment